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doi:10.1016/j.ejvs.2009.08.005Abstract Objectives: Previous studies have demonstrated elevation of systemic levels of
inflammatory cytokines after treadmill exercise in patients with intermittent claudication
(IC), but it is unknown if growth factor expression also is stimulated. The aim of this study
was to assess whether physical exercise-induced ischemia elicits an inflammatory response
and increase in local and systemic vascular growth factor expression in patients with IC.
Methods: Nineteen patients with IC had plasma concentrations of inflammatory markers (IL-6,
TNF-alpha, hs-CRP) and vascular growth factors (VEGF and FGF-2) measured before and at four
time points after a treadmill exercise test. In 10 patients a gastrocnemius muscle biopsy was
obtained to measure VEGF and FGF-2 mRNA. Plasma concentrations of vWF were also
measured. Five patients who underwent the treadmill test without experiencing calf pain were
enrolled as controls.
Results: Plasma concentrations of IL-6 increased after exercise (pZ 0.004), while TNF-alpha
and hs-CRP were unchanged (pZ 0.191 and pZ 0.709, respectively). Plasma concentrations
of VEGF were similar (pZ 0.151) at the different time points after exercise but FGF-2 levels
decreased (pZ 0.013). In biopsies after treadmill testing VEGF-A mRNA was increased
(pZ 0.043), but no change was observed for FGF-2 (pZ 0.456).
Conclusion: Exercise in IC triggers an inflammatory response as exemplified by elevated
concentrations of IL-6. After exercise-induced pain, VEGF mRNA in calf muscle is increased.
Therefore, it is plausible that angiogenesis is stimulated by exercise in IC.
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Peripheral arterial disease (PAD) is common and affects
about 20% of the population above the age of 60, and 7%
have intermittent claudication (IC).1 PAD, including IC, isd by Elsevier Ltd. All rights reserved.
690 U. Palmer-Kazen et al.a strong marker for future cardiovascular events and
increased mortality.2 Several studies have demonstrated
that hemostatic markers as D-dimer and thrombin-anti-
thrombin levels are elevated systemically in patients with
PAD compared to controls,3,4 and more recently increases
in inflammatory and endothelial biomarkers have been
observed.5
While pharmacological risk reduction is mandatory,
invasive procedures to reduce symptoms are not indicated
for most IC patients. Physical exercise is the primary
treatment strategy, but the mechanisms explaining why
exercise therapy is beneficial are unknown. Adaptation and
improvement of the energy metabolism in the muscle is
probably most important, and to a lesser extent (around
30%) blood flow improvement contributes.6,7 Collateral
growth, arteriogenesis, may be a process that enhances
blood flow when the patient exercises. Its development is
rather complex involving several steps such as increases in
shear stress against the vessel wall, production of cyto-
kines, a local vessel wall inflammation and finally remod-
elling and enlargement of the arterioles into large
collateral arteries.8,9 Besides arteriogenesis formation of
new capillaries, angiogenesis, may also be of importance
for improvement of tissue perfusion following exercise in
IC. Hypoxia, the most important trigger for angiogenesis,
may be involved in IC patophysiology, i.e. when the pain
forces the patient to stop walking. This hypoxic initiation of
angiogenesis involves production of vascular endothelial
growth factor (VEGF).10,11 However, patients with chronic
PAD have very low levels of VEGF in distal muscle compared
to proximal parts of the leg.12 In patients with chronic leg
ischemia and ischemic heart disease, elevated systemic
levels of fibroblast growth factor-2 (FGF-2) have been
reported.13,14 It is not known whether growth factor
expression is stimulated in IC patients reaching the abso-
lute claudication distance (ACD).
Better knowledge of endogenous arteriogenesis and
angiogenesis in PAD may lead to understanding of the
effects of exercise therapy and will impact development of
new therapeutic strategies. Accordingly, the aim of this
study was to assess whether physical exercise-induced
ischemia will cause an inflammatory response and local
vascular growth factor expression that may play a role for
these two reparative processes in patients with IC.
Materials and methods
Study population
Participants were recruited from consecutive patients
referred to the Vascular Surgery Department for evaluation
of PAD. Inclusion criteria were strict; ankle-brachial index
(ABI) between 0.5 and 0.8 and a reproducible ACD, defined
as <20% difference in two consecutive treadmill tests, and
ACD had to be between 1 and 6 min. Patients with diabetes
mellitus, severe heart failure, and myocardial infarction
within 6 months or unstable angina, neoplastic, immuno-
logic or chronic inflammatory diseases were excluded. A
large number of patients were screened using medical
records and interviews, and during the treadmill tests
further patients were excluded. Accordingly, the patientswere not representative for IC patients in general and
selected in order to identify a group with reproducible
walking distances and as little concomitant diseases as
possible.
Six screened patients, who fulfilled all criteria with one
exception e they had ACD longer than 6 min and walked for
a mean of 12 min (range 10e16 min) on two consecutive
treadmill tests served as a control group with the purpose
to enable evaluation of cytokine expression after exercise
in patients without muscle pain. Evaluation of data from
this group was considered exploratory only and they did not
participate in the biopsy substudy.
The hospital’s Ethics committee approved the study
protocol. All patients gave written consent to participate
after receiving oral and written information.
Study procedure
Patients visited the hospital on a separate day to have ABI
measured and to perform qualifying treadmill tests. The
treadmill was set at 3.2 km/h and a slope of 14% was used.
Included patients returned a few days later for the main
investigations. At that time resting baseline measurements
(ABI, blood samples, and biopsies when applicable) were
performed 1 h before the exercise test. The patients then
walked on the treadmill until ACD, rested 5 min, and per-
formed another test until ACD. After walking, ABI was again
measured within 2 min and blood samples drawn at 15, 60
and 120 min afterwards. The levels of high sensitivity CRP
(hs-CRP), interleukin 6 (IL-6), tumor necrosis factor alpha
(TNF-alpha) and the vascular growth factors VEGF and FGF-
2 were analyzed at all these time points. A second biopsy
was to obtain 120 min after the test in some of the patients.
The time points selected for investigation were based on
available literature covering exercise and cytokine
expression as wells as our hypotheses on possible mecha-
nisms of action.15e17
Blood sample analysis
Blood samples were drawn from the antecubital vein and
plasma separated by centrifugation within 30 min. Plasma
was frozen for later analysis of vWf (LIA-test), hs-CRP (using
particle enhanced immunonephelometry), IL-6 and TNF-
alpha samples (both by ELISA). Growth factors samples
were centrifuged within 2 h at 2000  g for 20 min, the
plasma separated and stored at 80 C for subsequent
analysis. The concentrations of total human VEGF and FGF-
2 in plasma were determined using ELISA (Quantikine High
Sensitivity human FGF basic Cat no HSFB75 and Quantikine
human VEGF Cat no DVE00, R&D Systems, Minneapolis, MN).
Each analysis included a standard solution of VEGF or FGF-2
and all standards and samples were run in duplicate. All
techniques and materials were used according to the
manufacturer’s instructions.
Microbiopsy procedure
Ten of the patients underwent percutaneous muscle biop-
sies before and after the test. A spring-loaded, reusable
instrument, Bard Magnum Biopsy Instrument, kindly
provided by BARD (BARD Norden AB, Helsingborg, Sweden)
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neous biopsies of various tissues18 and has recently been
evaluated for skeletal muscle in a validation study19 by
comparing it to needle biopsy according to Bergstro¨m. Core
tissue biopsy needles, 12 Gauge (Bard Magnum, MN1210,
BARD), with a sampling notch length of 19 mm and a pene-
tration depth of 15 mm was used.
Under local anaesthesia (2 ml of lidocaine 10 mg/ml),
the skin was incised 20 cm medially below the knee using
a scalpel and the biopsy needle inserted until the fascia was
pierced. The muscle sample was obtained in the gastroc-
nemius muscle by activation of a trigger-switch that
protrudes the needle. The biopsy needle was then pulled
out and the sample immediately frozen on dry ice. The
needle was inserted one to two additional times through
the same incision using other directions to obtain sufficient
amounts of tissue (10e15 mg). The procedure was repeated
after the exercise test using a new puncture site placed
1 cm from the first one. All biopsies were performed by the
same investigator (UPK).
mRNA expression
Total RNA was isolated using RNeasy Mini Kit (Qiagen). cDNA
was obtained using MMLV reverse transciptase (Invitrogen,
Carlsbad, CA) according to protocols of the kits. cDNA were
amplified by real-time PCR with primer and probe pairs to
human VEGF-A and FGF-2. GCCCACTGAGGAGTCCAACA and
TCCTATGTGCTGGCCTTGGT were used as primers for VEGF-
A and CACCATGCAGATTATGCGGATCAAACC as probe (FAM
labeled) and TGTGTCTATCAAAGGAGTGTGTGCTA and
TCCGTAACACATTTAGAAGCCAGTA were used as primers for
FGF-2 and CCGTTACCTGGCTATGAAGGAAGATGGAAG as
probe (FAM labeled). Predeveloped human glyceraldehyde-
3-phosphate-dehydrogenase (GAPDH) was used toTable 1 Clinical characteristics of patients with intermittent c
Patient characteristics Main group (treadm
N 19
Age (years, mean, SD) 69.1 (53e85)
Sex: F:M (N ) 11:8
Smoking status (N ):
yes e current 4
no e stopped >1 year ago 13
no e never 2
Hypertension (N ) 11
Coronary artery disease (N ) 5
Drug treatment at inclusion (N ):
Aspirin 11
Statins 10
Duration of claudication (N )
<3 months 4
6 monthse1 year 3
>1 year 12
Medical history walking distance
(meters, median, minemax)
250 (50e1000)
Bilateral leg problems (N ) 4
ACD, absolute claudication distance.normalize for RNA loading (Applied Biosystems). The reac-
tions were performed using TaqMan Universal PCR, Master
Mix (Applied Biosystems, Foster City, CA) in multiplex using
an ABI 7700 Prism Sequence Detection System (Perkin
Elmer). The cycle was configured as follows: incubation
(95 C, 10 min), 50 cycles of denaturation (95 C, 15 s), and
annealing/extension (60 C, 60 s). The PCR was performed
in multiplex for studied gene and 18S rRNA as internal,
endogenous control. This technique amplifies studied gene
and internal control in same tube. External relative stan-
dard curves were prepared by serial dilution of cDNA from
patients with highest expression of VEGF-A and bFGF. Each
run consisted of standards and a negative control without
template.
Statistics
Results were expressed as median and range. Analysis of
variance (ANOVA) was used to compare data over time for
IL-6 and TNF-alpha. For post-hoc comparisons, Scheffe´s
test was applied. Paired Student’s t-test between two
dependent groups was calculated for comparisons of ABI
and vWf before and after exercise. When not normally
distributed, Wilcoxon signed-rank test (VEGF-A and FGF-2
mRNA) or Friedman ANOVA by ranks (hs-CRP, VEGF and FGF-
2 in plasma) was used. The mRNA analysis was considered
as exploratory and we hypothesized that reaching ACD
would increase mRNA levels in every patient. No proper
power analysis was performed due to lack of previous data.
In some patients mRNA levels were below detectable levels
and in the non-parametric statistical analysis levels were
then considered to be zero. Statistical analysis was per-
formed using Statistica StatSoft software and for all anal-
yses p-values <0.05 were considered statistically
significant.laudication enrolled in the study.
ill ACD <6 min) Controls (treadmill ACD >10 min)
5
72 (58e76)
2:3
3
2
3
2
4
1
NA
NA
NA
Figure 1 Individual data of ankle-brachial index (ABI) before and 2 min after treadmill exercise in patients with intermittent
claudication (IC) reaching (main group) and not reaching (controls) absolute claudication distance (ACD). Dashed lines demonstrate
subjects with decreased values compared to base line.
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Study population
Nineteen patients IC were included in the main group of
whom 10 participated in the muscle biopsy substudy. The
exploratory control group consisted of only five patients
because one patient withdrew from the study. None of the
patients experienced any severe inconveniences during or
after the treadmill test or biopsy. Their demographic andFigure 2 Box plots of IL-6 plasma levels of in patients with claudic
experiencing calf pain quartiles are displayed, and for the main gro
IL-6 values increased compared to base line (main group, pZ 0.00clinical characteristics are presented in Table 1. There was
a significant reduction in ankle-brachial index after tread-
mill exercise in both groups (Fig. 1).
Plasma levels of inflammatory parameters
Plasma levels of IL-6 increased after the treadmill test
(pZ 0.005; Fig. 2). TNF-alpha and hs-CRP were similar
post-exercise (pZ 0.191 and pZ 0.709, respectively, data
not shown). Five of the patients in the main study groupation before and after treadmill exercise. For control group not
up the graph includes quartiles, minimum and maximum values.
5, ANOVA).
Figure 3 Individual data of von Willebrand factor plasma levels before and 120 min after treadmill exercise in patients with
intermittent claudication (IC) reaching (main group) and not reaching (controls) absolute claudication distance (ACD). Dashed lines
demonstrate subjects with decreased values compared to base line.
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as the normal upper limit by our hospital laboratory. A
small but significant (pZ 0.034) decrease was noted for
vWf (Fig. 3). In the control group the plasma concentra-
tions of IL-6 showed a similar pattern as in the patients
reaching ACD with an increase after the treadmill exercise
(Fig. 2).
Plasma levels of VEGF and FGF-2
There were large individual variations in systemic growth
factor levels at base line. VEGF concentrations were similar
(pZ 0.151) at the different time points (Fig. 4A) but for
FGF-2 a decrease (pZ 0.013) was observed after the
treadmill test (Fig. 4B).
Skeletal muscle mRNA levels
Real-time PCR analysis of VEGF-A (NZ 10) mRNA demon-
strated a 19% (pZ 0.043) increase in expression 120 min
after exercise as compared with pre-exercise levels (Fig. 5)
and for FGF-2 mRNA no change (pZ 0.456) was observed
(not shown). In one patient a biopsy had VEGF-A mRNA
concentrations below the limits of detection, and five
patients had amounts of FGF-2 mRNA below the limits of
detection in either one or both of the samples.
Discussion
The principal finding in this study is that exercise to clau-
dication on a treadmill results in increased plasma IL-6,
while TNF-alpha and hs-CRP remained unchanged.
Furthermore, treadmill exercise reaching ACD causes
a decrease in plasma FGF-2 and an increased expression of
VEGF-A mRNA in calf muscle biopsies.There is substantial evidence in the literature that
inflammation is involved in arteriogenesis and angiogenesis
occurring during limb ischemia15,20 but published data
suggesting a systemic inflammation in PAD has several other
more plausible explanations than these two processes. It
may for instance, be attributed to generalized atheroscle-
rosis and plaques releasing cytokines into plasma.21,22 In
line with this a recent study reported higher levels of CRP
and vWf in PAD patients than in healthy controls.3 CRP
concentrations were not influenced by exercise in the
patients included in this study, a finding supported in the
literature.23 The potential release of CRP from plaques is
probably not affected by this exercise provocation. In
contrast, vWf did appear to be released from endothelial
cells or platelets during or following exercise. Plasma
concentrations are reported to remain elevated for up to
60 min after exercise24 and the rise in vWf in response to
exercise is greater in healthy subjects.25 However, we
observed a decrease in vWf following exercise, as have
other groups.26,27 The vascular pathophysiology in PAD may
explain this contradiction. Changes in shear forces during
exercise are probably not strong in vascular beds distal to
an arterial occlusion, and the damaged endothelial cells in
the vasculature of PAD patients are likely to have a reduced
ability to release vWf. Our protocol of walking to ACD twice
may have caused an extensive release of vWF that led to
depletion in the parts of the vascular bed effected by
exercise-dependent changes in shear forces.
TNF-alpha concentrations have been reported to rise
after exercise in PAD patients,5 but this was not observed
here, perhaps due to the study design. However, we did
demonstrate increased concentrations of IL-6 in plasma
after exercise at the later time points, a finding that is
supported by a previous study.5 IL-6 could either have been
released from skeletal muscle or from locally activated
monocytes in the ischemic calf.28,29 It maybe that
Figure 4 Box plots (median and quartiles) of VEGF-A (A) and FGF-2 (B) protein concentrations in plasma before, 15, 60 and
120 min after treadmill exercise in main patient group. No difference was observed for VEGF over time (pZ 0.151), but FGF-2
levels decreased significantly (pZ 0.013, Friedman ANOVA by ranks).
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induced by increases in shear stress, contributed to our
findings.30
One of the most potent stimulants of angiogenesis is
hypoxia, a metabolic state known to occur in the calf of IC
patients when reaching ACD.31 Hypoxia upregulates HIF-1
alpha, which stimulates the transcription of the VEGF
gene.32 Hence, transcription of VEGF mRNA is upregulated
by exercise in both healthy individuals and patients with
heart failure.11,33 We observed that calf muscle VEGF mRNA
concentrations increased after exercise to claudication and
we infer that either transcription was upregulated or the
mRNA was stabilized. The local increase in mRNA was not
reflected in the plasma levels of this protein during the
short time period studied. This absence of an increase of
plasma VEGF-A concentration after exercise to claudication
has been noted previously.34Although FGF-2 is a locally acting growth factor that is
not circulated and its biological actions stem from its
release from storage sites within the extracellular matrix
and subsequent local interaction with surface receptors of
endothelial cells rather than modification in the total
content.35 Continuously elevated plasma concentrations
of FGF-2 have been observed in patients with PAD.12
Higher FGF-2 levels are found in distal ischemic muscle
samples from patients with PAD compared to proximal
non-ischemic parts of the same leg.14 Few patients in our
cohort had measurable levels of FGF-2 in skeletal muscle,
and the mRNA data was unreliable. However, we observed
a clear decrease in plasma FGF-2 concentrations after
exercise to claudication. One possible explanation of this
observation would be that binding of FGF-2 to extracel-
lular matrix increase as a result of the exercise pro-
vocation test.
Figure 5 Individual data of VEGF-A mRNA concentrations of in calf muscle biopsies in main patient group before and 120 min
after treadmill exercise. Dashed line demonstrates decreased values compared to base line. One patient had values below the
detectable level at base line and only the post-exercise data is displayed.
Exercise Induced Growth Factor Expression in Claudication 695The local and systemic consequences of exercising to
ACD for IC patients largely are uncharted. Whilst our find-
ings may not be generalisable to all IC patients, they add
weight to the possibility that exercise provokes the release
of IL-6 from either atherosclerotic lesions or, skeletal
muscle or an activated endothelium. Hypoxia in the calf
caused by the walking test leads to increased concentra-
tions locally of VEGF, suggesting initiation of angiogenesis
in IC when walking to ACD.Acknowledgements
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